Sotagliflozin
STUDY00000249
Phase 3 small_molecule active
Quick answer
Sotagliflozin for Diabetic Nephropathies is a Phase 3 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Diabetic Nephropathies
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active